Country Profile at a Glance

Market Overview

Healthcare Infrastructure

Costa Rica's CCSS (Caja Costarricense de Seguro Social) is one of Latin America's best-funded and most efficient public healthcare systems, operating 29 hospitals and over 250 EBAIS (Equipos Básicos de Atención Integral en Salud) primary care units. The CCSS manages centralised procurement through a well-organised tender system. The private sector includes Clínica Bíblica, Clínica Católica, Hospital CIMA, and a growing cluster of specialist clinics serving Costa Rica's active medical tourism industry — the country received over 100,000 medical tourists in 2024. Boston Scientific, Abbott, Medtronic, Edwards Lifesciences, and Smiths Medical all have manufacturing operations in Costa Rica's free trade zones.

Key Market Drivers

• Highest GDP per capita in Central America: premium market with quality-oriented procurement
• CCSS universal healthcare: well-funded centralised procurement system with structured tender processes
• Medical tourism cluster: 100,000+ annual medical tourists driving private hospital investment in premium equipment
• Central American regional headquarters: most international medtech companies use San José as their LATAM or CA regional base
• Free trade zone medical device manufacturing: Costa Rica's medtech FTZ cluster creates ecosystem knowledge and quality standards
• SIECA Central American integration: Costa Rica registration is the most credible anchor for a SIECA five-country strategy

Top Product Categories in Demand

Regulatory Environment

Framework & Authority

Medical devices are regulated by MINSA/PNCM (Programa Nacional de Control de Medicamentos) under the Ministry of Health. CE Mark or FDA clearance is the primary quality evidence. A licensed Costa Rican importer is required. Registration typically takes 3–9 months. Costa Rica is the most regulatory-sophisticated SIECA member — a PNCM registration in Costa Rica is the highest-credibility anchor for a Central American regulatory strategy, facilitating registration in Honduras, El Salvador, Guatemala, and Nicaragua.

Key Registration Requirements

• PNCM device registration — CE Mark or FDA clearance as primary evidence
• Licensed Costa Rican importer/distributor required
• Spanish-language labelling and Instructions for Use mandatory
• SIECA framework: Costa Rica registration facilitates Central American regional registration
• Import duty: 0% for most medical devices (DR-CAFTA framework)

Import & Trade Data

Costa Rica imports the majority of its medical devices from the USA, Germany, Japan, and the Netherlands. US suppliers dominate the private sector; European brands are strong in CCSS procurement. Turkey's share (~1.4%) is growing. San José is also the regional distribution hub for many international manufacturers serving the whole Central American market — a San José-based distributor is the most strategic Central American appointment for Turkish manufacturers.

Opportunities for Turkish Exporters

• CCSS tender participation: Costa Rica's social security procurement system is well-organised, transparent, and accessible to internationally registered CE-certified suppliers with competitive pricing
• Medical tourism private hospital: Clínica Bíblica and Hospital CIMA serve international patients and have procurement standards comparable to Miami or Madrid private hospitals
• SIECA anchor registration: a PNCM Costa Rica registration is the most credible starting point for a five-country Central American regulatory strategy — other SIECA markets follow more easily from Costa Rica
• San José regional distribution: appointing a San José-based distributor gives access to all five Central American markets through the region's most experienced medical device commercial infrastructure
• Medtech FTZ ecosystem: multinational medtech manufacturing presence in Costa Rica's FTZs creates OEM component and contract manufacturing opportunities for Turkish medical manufacturers

Challenges & Considerations

• Sophisticated buyer standards: Costa Rican CCSS and private hospital buyers have high technical and clinical documentation expectations — bring clinical evidence, not just CE marking
• Competition from US and European brands: the premium market is well-served by leading international brands; Turkish products must compete clearly on quality-to-price value
• Small population: 5.5 million people requires regional strategy to achieve commercial scale
• CRC currency fluctuation: USD contract terms standard for international medical device supply

Conclusion

Costa Rica is the essential anchor of any Central American medical device market strategy — simultaneously the region's highest-income market, its most credible regulatory reference point, and its most active regional distribution hub. Turkish manufacturers who secure PNCM registration, appoint a San José-based regional distributor, and leverage the SIECA framework will access the entire Central American market of 45+ million people from the region's most sophisticated commercial platform.